6th Global NASH Congress I Tribun Health

[MARCH 2ND-3RD, 2023]

The global medical community continues to face a significant challenge in the fight against non-alcoholic steatohepatitis (NASH), as no treatment has yet been officially approved by the FDA. Considering the increasing global burden of NASH, development of suitable therapeutic strategies is a crucial clinical need. During this congress, Tribun Health will highlight its robust and scalable AI-based models for NASH drug development, as well as commercial strategies to help accelerate NASH in the future.

Tribun Health will be giving talk on its innovative solutions for NASH on March 2nd from 3:00-3:15 PM BST in the track entitled: "Diagnosis, Staging, and Risk Assessment for NASH". Our team will also be available to discuss your projects at the Tribun Health booth during the congress. 

Learn more about the event